The FDA is allowed to visit your company to perform an inspection. In the course of the visit they may bring some issue to your attention in the form of an observation (aka a 483). This article reviews what a 483 looks like, some of the more common issues flagged in medical device companies, and how to respond.
We invite you to download our paper on the topic of 483 Observations.
Managing your organization’s knowledge base may be challenging, especially if information is scattered across multiple systems. Discover how Atlassian’s AI Rovo agents help manage this.What You Will Learn In this eBook you will discover: Why knowledge management...
As the medical device industry continues to innovate at breakneck speed, it now faces a new headwind: sweeping tariffs introduced in 2025 by the U.S. government and mirrored by key global trade partners. These changes are creating a ripple effect across the global...
Structuring ideas and aligning discovery work with delivery goals is crucial for product managers, but it’s not always easy. Atlassian’s Jira Product Discovery (JPD) has become a go-to solution for organizing ideas, insights, and roadmaps within a unified platform....
When it comes to CAD collaboration, distance can create unique challenges. While remote work solves some of these issues, working together can still be challenging, especially without the right tools. Large design files, software compatibility, and communication...